The molecular basis of aging and of aging-associated diseases is being unraveled at an increasing pace. An extended healthspan, and not merely an extension of lifespan, has become the aim of medical practice. However, a precise definition of health and healthspan is not straightforward, and the causal molecular basis of health "per se" is largely unknown. Here, we define health based on the absence of diseases and dysfunctions. Based on an extensive review of the literature, in particular for humans and C. elegans, we compile a list of features of health and of the genes associated with them. Clusters of these genes based on molecular interaction data give rise to maps of healthspan pathways for humans, featuring the themes transcription initiation, proliferation and cholesterol/lipid processing, and for C. elegans, featuring the themes immune response, mitochondrion and biosynthesis based on genetic and compound intervention data, and lipids, biosynthesis and transcription based on WormBase compound intervention data. Overlaying healthspan-related gene expression data (describing effects of metabolic intervention associated with improvements in health) onto the aforementioned healthspan pathway maps, we observe the downregulation of Notch signalling in humans and of proliferation/cell-cycle in C. elegans. The former reflects the proinflammatory role of the Notch pathway. We identify transcription, proliferation/biosynthesis and lipids as a common theme on the annotation level, and proliferation-related kinases on the gene/protein level. Our literature-based data corpus, including visualization, is available as a reference for future investigations, at
Introduction
For a long time, an active, targeted intervention to maintain health into old age was terra incognita. It had no priority, and few, if any, reliable data were available to implement it in everyday life. Today, however, systematically established diagnostic hints become available for the individual, based on family history and biomarker data, including genetic variants (polymorphisms). To assess and prevent premature health deterioration successfully, it would therefore be useful (1) to dissect "health" into a set of its most important features, (2) to detail its molecular basis and to map out molecular "healthspan pathways", and (3) to specify biomarkers and corresponding supportive interventions for the various features of health and for health itself. Arguably, the increase in life expectancy in the last 100 years has not been accompanied by an increase in disease-free life expectancy (Crimmins, 2015) , (Robine, Jagger, & Crimmins, 2013) . Cardiovascular disease, type-2 diabetes and neurodegenerative disorders are highly prevalent in the elderly, and these disorders frequently coexist in the same aged individual, often with mutual reinforcement (Fillenbaum, Pieper, Cohen, Cornoni-Huntley, & Guralnik, 2000) . Extending healthspan may thus enable economic, societal and individual gains on a large scale (Fuellen et al., 2016) .
Intervention studies to prolong healthspan based on compound exposure in humans are limited to relatively few compounds. Resveratrol for instance, being one of the beststudied poly-phenols in humans and animals, has been tested in several clinical studies (Berman, Motechin, Wiesenfeld, & Holz, 2017) . These include studies focused on biomarkers, like the level of blood glucose (Brasnyó et al., 2011) and cholesterol (S. Chen et al., 2015) , or glutathione S-transferase expression (Ghanim et al., 2011) .
However, data about long-term effects on overall health in human are missing in general, and given the average human life expectancy, they are difficult to obtain. Therefore, model organisms are of great relevance to uncover the molecular basis of healthspan and to identify supporting compounds. The nematode Caenorhabditis elegans (C. elegans) is a widely used model organism for studying ageing which guided the discovery of fundamental ageing-related findings, e.g., on calorie restriction and Insulin/IGF-1 like signaling (Gruber et al., 2015) . Last not least, around 40% of the genes found in C. elegans have human homologues (Shaye & Greenwald, 2011) and studies revealing the role of metabolism on health conducted in C. elegans have been subsequently strengthened in murine models (Berry & Cirulli, 2013) , rendering this nematode a valuable model for human ageing processes. Most recently, C. elegans has come to enjoy increasing popularity as a model for health (Sutphin et al., 2017) , (Luyten et al., 2016) , and an ever increasing number of compounds are tested in C.
elegans for their anti-ageing and health effects (Chen, Barclay, Burgoyne, & Morgan, 2015) , (Luo, Wu, Brown, & Link, 2009) , (Collins, Evason, & Kornfeld, 2006) , (De Haes et al., 2014) .
Here, we assemble and explore "healthspan pathway maps", that is, annotated sets of interacting genes implicated in health. To create these, we follow a stepwise procedure: first, we dissect health into its various features, with an emphasis on disease and dysfunction. Second, we compile lists of genes associated with health based on the literature, for humans and C. elegans. Third, we organize these genes into maps of healthspan pathways, based on gene/protein interaction and annotation data. Fourth, we create an overlay of health-related gene expression data onto the resulting healthspan pathway maps, highlighting corroborating knowledge that was not used as input. Finally, we investigate the overlap of the healthspan pathways in humans and C. elegans.
For humans, we consider that knowledge of the causal basis of health may be best derived from genetic association studies. Based on an extensive review of the literature, we identify a core set of 12 genes that are genetically associated with a lack of frailty (Mekli, Marshall, Nazroo, Vanhoutte, & Pendleton, 2015) , (Ho et al., 2011) and the Healthy Aging Index (Sanders et al., 2014) , and another set of 40 genes genetically associated with (a lack of) multiple diseases, or with longevity mediated by a lack of disease (see Supplementary Tables 1-3 ). In contrast to humans, genetic intervention studies on healthspan are available for C. elegans, as well as compound intervention data. A lack of dysfunction exemplified by stress resistance, locomotion, pharyngeal pumping and reproduction are taken as the key health features in C. elegans (Rollins, Howard, Dobbins, Washburn, & Rogers, 2017) . On this basis, a core set of 11 genes is directly implicated in improvements of locomotion by genetics, and another set of 20 genes is indirectly implicated in improvements of the key health features by studies that investigate effects of compounds (see Supplementary Tables 4 and 5 ).
We then place the genes implicated in health into context by adding gene/protein interaction and gene annotation knowledge. Specifically, we turn the lists of genes into gene/protein interaction networks, to which 20 closely interacting genes are added, employing GeneMania (Zuberi et al., 2013) . Gene ontology annotation data are then used to annotate clusters of strongly connected genes within the network, employing AutoAnnotate (Kucera, Isserlin, Arkhangorodsky, & Bader, 2016) . Then, we elaborate how the resulting healthspan pathways can be interpreted in plausible ways, specifically in the light of independent health-related gene expression data describing effects of caloric restriction and of rapamycin, and in the light of gene expression data describing aging and disease. We also predict microRNAs that may be potential regulators of healthspan. Finally, we find that if we construct an overlap between the healthspan pathways in C. elegans and humans, we find genes involved in transcription, proliferation/biosynthesis and lipids, but this overlap it is not straightforward to interpret in the light of the independent health-related gene expression data that we used to test plausibility of the single-species healthspan pathway maps. Defining Health. Health is a term in biology and medicine that is hard to define. We propose that the best definition of health must be based on an aggregation of the literature, see also (Fuellen et al., 2018) , (Luyten et al., 2016 terms of interventions, we are interested in preventing more than one disease. As described and discussed in (Fuellen et al., 2018) , not all parts of the ICD feature diseases related to health and healthspan. However, we note that all diseases referred to in Supplementary Tables 1-3 Genes associated with health. Our list of health genes, that is, genes with associations to health in humans are based on genetic association, and we can assume some probability of them being causal, leaving aside the intrinsic ambiguities to assign polymorphisms (in the form of SNPs, single-nucleotide polymorphisms) to genes, e.g. in intergenic regions or in intronic regions with overlapping non-coding RNA on the complementary strand (Schwarz et al., 2008) . In turn, for C. elegans, few studies report effects of genetic interventions on health, though these are increasingly becoming available; (Sutphin et al., 2017 ) is the only large-scale genetic study that we could identify as of early 2018, even though it is essentially a small-scale study of healthspan based on a large-scale study of lifespan. Many more studies in C. elegans refer to canonical aging-related pathways, and in contrast to studies in humans, these studies often directly report the molecular effects of compound intervention. The C.
elegans genes listed in the supplementary tables are thus based on the effects of genetic intervention and on the effects of compound intervention on the gene level, and we can assume a high probability of causality in both cases.
Additional genes associated with C. elegans health. For C. elegans, we generated an additional list of health-associated genes that cannot be generated for humans (see Experimental Procedures), using WormBase to systematically identify health-related compound interventions with associated gene expression data, and compiling the list of genes with strongest differential expression that are well-annotated by Gene
Ontology terms.
From gene lists to maps of healthspan pathways. We used Cytoscape and some of its application plugins as the most straightforward tool for obtaining and annotating a connected network of the genes from Supplementary Tables 1-3 and from   Supplementary Tables 4 & 5 . Specifically, we used GeneMANIA to establish a gene/protein interaction network and to add connecting genes, and subsequently we clustered all genes based on their connectivity, and added GO-based annotations, using AutoAnnotate. The resulting healthspan pathway maps are presented in the following. Moreover, health-related gene expression data are overlaid onto all healthspan pathway maps and will be discussed as well; these data are describing the effects of caloric restriction (CR) in humans (Mercken et al., 2013) and of rapamycin in C. elegans (Calvert et al., 2016) , as examples of health-promoting interventions, or they describe the effects of aging and disease in specific tissues. In the largest pathway/cluster, in light of the CR-triggered gene expression changes, the most prominent findings are an induced downregulation of NOTCH4 (and to a lesser extent of NOTCH 2&3), as well as of LRP1, and an upregulation of TOMM40
and CREBBP (also known as CBP). The family of NOTCH proteins has various functions, including a pro-inflammatory one (Balistreri, Madonna, Melino, & Caruso, 2016) , (Zhang, Kuang, Wang, Xu, & Ren, 2017) . NOTCH4 is upregulated in kidney failure (Liu et al., 2017) , and promotes vascularization/angiogenesis, which includes its upregulation in malignancy (Zhang et al., 2017) , (Kofler et al., 2011) . A downregulation of NOTCH4 by CR can thus be taken as beneficial effect. This is less obvious for LRP1, the low-density lipoprotein receptor-related protein 1, which is responsible for membrane integrity and membrane cholesterol homeostasis, thus 8 being involved in proper myelination (Lin, Mironova, Shrager, & Giger, 2017) and vascular integrity (Strickland, Au, Cunfer, & Muratoglu, 2014 expression actually reflects a lower LDL level, which per se has been found to be protective, assuming brain levels to follow plasma levels. The upregulations observed for TOMM40 and CREBBP during CR can also be seen as protective. TOMM40 is part of a mitochondrial membrane protein translocase, supporting mitochondrial function (Zeitlow et al., 2017) , and low expression and/or particular risk alleles of this protein are associated with Huntington's and Alzheimer's Disease (Shirendeb et al., 2011) , (Chong et al., 2013) . Of note, TOMM40 upregulation during CR goes together with APOE4 downregulation. Although both genes are closely located on chromosome 19, prompting the speculation that this linkage could imply concordant expression changes, this is obviously not the case here. CREBBP is a transcriptional co-activator with histone-acetyltransferase activity (Bedford & Brindle, 2012) , acting primarily on histones 3 and 4, and thus it acts in concert with a range of transcription factors. Its downregulation is deleterious, resulting in, e.g., MHCII expression loss on lymphocytes (Hashwah et al., 2017) , rendering the lymphocytes dysfunctional for antigen presentation, and in inflammatory signalling (Dixon et al., 2017 ). An upregulation of CREBBP by CR is thus likely beneficial. We further investigated the miRNAs that are statistically enriched in the largest healthspan pathway using the TFmir webserver (Hamed, Spaniol, Nazarieh, & Helms, 2015) , revealing regulation of NOTCH genes implicated in the epithelial-mesenchymal transition, cancer, heart failure and obesity, see Supplementary Results. The genes in the next-largest pathway/clusters, related to cell proliferation and lipids, are also described there in detail, as well as further evidence provided by mapping aging-and disease-related gene expression data onto them, as published or collected by (Aramillo Irizar et al., 2018) .
For C. elegans, the gene list derived from Supplementary Tables 4-5 (see Suppl. Table   7 ) yielded the network of Figure 2 , where the largest clusters (9 and 6 genes, respectively) are labeled by immune response process and by terms related to the mitochondrion. Three clusters (of 4 genes each) specifically feature dauer/dormancy, regulation and hormone response. In Figure 2 bottom, the list of pathways/clusters, and the details of the largest pathway are zoomed in. Regarding the first pathway, rapamycin induces ets-7 transcription, which was shown to be also necessary for the healthspan-promoting effects of salicylamine (Nguyen et al., 2016) . Furthermore, rapamycin upregulates the transcription factor daf-16 (a homolog to Foxo) and downregulates the daf-16 inhibitors akt-1 and akt-2, putatively leading to an improved stress-and immune-response and prolonged lifespan via the Insulin/IGF-1 pathway (Henderson & Johnson, 2001) . Along the same lines, the akt-1 and akt-2 activator pdk-1 is also downregulated by rapamycin, further promoting daf-16 activity (Paradis, Ailion, Toker, Thomas, & Ruvkun, 1999) . In contrast, the daf-16 inhibitor sgk-1 (a homolog to Nrf) is upregulated; however, its inhibitory role is subject of discussion (Mizunuma, Neumann-Haefelin, Moroz, Li, & Blackwell, 2014) . Finally, the transcription factors hsf-1 and skn-1, both important in stress response processes (Morton & Lamitina, 2013) ; (Wang et al., 2010) , are slightly downregulated in rapamycin-treated C. elegans. In the Supplementary Results, the next-largest pathway/clusters, related to the mitochondrion, to dauer/dormancy, to regulation, and to hormone response are described in detail.
For C. elegans, we also derived a gene list from WormBase, taking the genes that are most differentially regulated by healthspan-extending interventions and, at the same time, are annotated with a sufficient number of GO terms (see Experimental Procedures; Suppl. Table 8 ). We obtained the network of Figure 3 . Curiously, the top healthspan pathways of 11, 9 and 8 genes are related to the endoplasmic reticulum (ER), lipid & membrane, to the peroxisome, macrobody & ER, and to the lysosome.
The endoplasmic reticulum, the peroxisome and the lysosome are part of the endomembrane system, together with the mitochondria, contributing to healthspan and longevity in mammals and beyond (Nisoli & Valerio, 2014) . Peroxisomal function connects this pathway to dietary effects on lifespan (Weir et al., 2017) , and to liver disease (Cai et al., 2018) . The second tier of healthspan pathways (6 or 5 genes) are related to morphogenesis, biosynthesis and transcription.
For the WormBase data, the list of pathways/clusters, and the details of the largest pathway, are given in Figure 3 , bottom. The ER/lipid-related pathway includes genes involved in fatty acid elongation/production (elo-1 to elo-9; let-767; art-1). Overlaying the rapamycin gene expression data, the well-characterized elo-1 and let-767 genes show negligible downregulation. However, the importance of elongase genes for health maintenance in general was repeatedly documented. Vásquez and colleagues (Vásquez, Krieg, Lockhead, & Goodman, 2014) demonstrated the impairment of touch response in elo-1 mutants. They argue that elo-1 has a crucial role in the synthesis of C20 polyunsaturated fatty acids which are required for mechanosensation. Moreover, elo-1 mutants showed increased resistance to Pseudomonas aeruginosa infections due to the accumulation of gamma-linolenic acid and stearidonic acid (Nandakumar & Tan, 2008) and knockdown of elo-1 or elo-2 extend survival during oxidative stress (Reis et al., 2011) . Finally, art-1 is a steroid reductase that is downregulated by rapamycin in our case, but also in long-lived eat-2 mutants (Yuan et al., 2012) . In the Supplementary Results, the next-largest pathway/clusters, related to the ER/peroxisome, the lysosome, morphogenesis, biosynthesis and transcription, are described in detail.
Overlap between human and C. elegans health genes and healthspan pathways.
Based on reciprocal best orthologs, we found no direct overlap between the human health genes based on genetic associations and the C. elegans healthspan genes based in part on genetic interventions, but mostly on expert analysis of intervention effects (Figure 2 ), or on gene expression changes related to healthspan-extending interventions ( Figure 3 ). We found some hints at an overlap on the level of the healthspan pathway annotations, considering that "proliferation" is listed for human, and "biosynthesis" for C. elegans, and "transcription" as well as "lipid" for both.
In search for other modes of overlap, we therefore constructed and compared two interaction networks, based on mapping genes to their respective orthologs in the other species. Each of the two interaction networks is based on the union set of the health genes of human (based in turn on genetics, Supplementary Tables 1-3, Figure 1 ) and of C. elegans (based in turn on the gene expression analysis of healthspan-extending interventions using WormBase, Figure 3) . Specifically, as outlined in Figure 4 , we added the C. elegans orthologs of the human health genes to the list of C. elegans health genes and vice versa, yielding two separate input gene lists for GeneMANIA to enable the construction of the two interaction networks. We used strict ortholog mapping rules (only reciprocal best hits were accepted). By design, the two gene lists feature a high degree of overlap (with differences due to missing orthologs), and their subsequent comparison, consisting of the partial network alignments that are based on ortholog mapping on the one hand and the species-specific network data on the other hand can only reveal hypotheses for common healthspan pathways, as long as explicit experimental evidence for a relation to health is only found for one species.
Moreover, interaction points between a healthspan pathway in one species and a healthspan pathway in the other species may be revealed, if a partial alignment of the interaction networks consists of interacting genes for which the relationship to health was demonstrated only in one species for each pair of orthologs.
Of note, of the two interaction networks to be aligned, the first network is based on C.
elegans health genes, the C. elegans orthologs of human health genes, and C. elegans gene interaction information provided by GeneMANIA. The second network is based on human health genes, the human orthologs of C. elegans health genes, and human gene interaction information provided by GeneMANIA. Despite using similar lists of genes (with differences due to missing orthologs and due to the genes added by GeneMANIA), we can expect that the two GeneMANIA networks are quite different because the interaction data sources employed by GeneMANIA are strongly speciesspecific. Moreover, we observe that in both cases, the 20 closely interacting genes added by GeneMANIA for one species included no orthologs of the other species.
Nevertheless, to identify joint healthspan pathways and interaction points between healthspan pathways, we used GASOLINE (Micale, Continella, Ferro, Giugno, & Pulvirent, 2014) to align the two networks wherever feasible, obtaining two partial (subnetwork) alignments as output, as shown in Figure 5 . the scope of this paper. But it should be mentioned that while health can be defined and investigated in C. elegans, this model is also fraught with an array of issues, some shared with organoid-based approaches, but also including some particularities of the species (post-mitotic tissues, artificial cultivation, hermaphrodite, genetic uniformity of strains, lack of organs present in humans such as a heart) and of our modes of investigation (limitations of the data currently available, limitations of healthspan assays in terms of their design and the controlled environment in which these are conducted). Nevertheless, for studies in a living system to be completed in a short time-frame, C. elegans is arguably the best choice.
Given lists of genes, there is a plethora of possibilities to organize the genes into groups of related ones. Motivated by the idea of a "healthspan pathway", we hypothesized that the genes should be known to interact based on functional gene/protein interaction data (provided by GeneMANIA). Here, as in most other studies, pathways are not assumed to be linear. The (higher-level) interaction among the clusters/healthspan pathways (i.e., the pathway map) is given by the individual gene/protein interactions that are shown between the clusters in Figures 1-3 . However, we did not investigate these further.
The small amount of healthspan gene/pathway overlap that we found may be seen from a pessimistic or an optimistic perspective, depending in part on expectations.
From the pessimistic perspective, the molecular processes may be completely different, and the C. elegans orthologs of the human health genes are involved in different processes as compared to the human health genes, and vice versa. From the optimistic perspective, it may just be that the number and scope of the investigations that yielded the health genes we studied is still insufficient, annotations are still incomplete, and considering only reciprocal best orthologs may be too restrictive. (We tried a less restrictive mapping of orthologs by relaxing the condition that orthologs must be reciprocal, but the overlap was still negligible; results not shown).
Nevertheless, future genetic studies are expected to yield more health genes in both species, and their characterizations are expected to improve. Moreover, when we analyze in detail the effects of intervention studies in C. elegans, we do find clear hints to some mechanisms that underlie healthspan also in human. For example, changes in the Ins/IGF-1 pathway genes daf-2 and daf-16 are found to be associated with many of the features described in Supplementary Table 5 , suggesting a fundamental role for immune defense mechanisms (and proliferation) in health maintenance, as described by (Ermolaeva & Schumacher, 2014) .
Of course, the precise definition of phenotype is crucial. If the samples are not really about (lack of) health, in human or in C. elegans, then any subsequent molecular or bioinformatics analyses will compare apples and oranges and may thus fail. Therefore, it is important to use a good phenotyping of health in human as well as in C. elegans, and on this basis, to collect data as genome-wide as possible. It is evident that there is no C. elegans counterpart to most of the (age-related) diseases that we use to define health in humans, and that the aging process that may underlie most of these agerelated diseases is poorly characterized and hard to quantify in humans. Nonetheless, locomotion degrades with age in both species, due to changes at the muscle as well as neural level. Two related features of physical function, that is, grip strength (Leong et al., 2015) and the ability to sit and rise from the floor (Brito et al., 2014) are good predictors of all-cause mortality in humans. Likewise, both in humans and in C.
elegans, the ability to withstand various forms of stress decreases with age (Dues et al., 2016) , (Bajorat et al., 2014) . Thus, at the level of organs or functional systems, both C. elegans and humans show age-related declines in performance, that may well be due to underlying processes that are similar at the cellular and molecular level. We claim that within the limitations of currently available data, the health genes we assembled, the healthspan pathways we constructed based on these, and the overlap we then found between species, are a first glimpse of the species-specific and crossspecies molecular basis of health.
Experimental Procedures
Gene sets associated with health, literature-based. In this work, we conducted a semi-systematic review, using health, healthspan and healthy aging, for human and C.
elegans, as search terms in Google Scholar, initially filtering for recent reviews and considering only the top hits. For humans, genetic studies of Supplementary Tables 1-3 are often not found using health-related keywords, so we included terms related to dysfunction (such as frailty) and disease (such as multi-morbidity) as well. For the genetics of human frailty, we identified two publications (Mekli et al., 2015) , (Ho et al., 2011 From the original publications and reviews, we extracted the gene names, using ihop (Hoffmann & Valencia, 2004) to assign HUGO nomenclature names if necessary. In the Supplement, we describe in detail how a second set of health-associated genes in C. elegans was identified using WormBase.
Construction of maps of clusters/pathways.
For all gene sets analyzed, we used the Cytoscape 3.5.1 application GeneMANIA (Zuberi et al., 2013) , version 3.4.1, downloaded October 2017, with default settings, to create a functional interaction network that is complemented with the GeneMANIA default of 20 connecting genes.
For clustering, and for annotating the clusters based on the "annotation name" column of GO annotations collected by GeneMANIA, we used AutoAnnotate (Kucera et al., 2016) v1.2, downloaded October 2017, in Quick start modus to enable to "layout network to prevent cluster overlap", so that a map of disjoint clusters (healthspan pathways) was generated, supplemented by a second advanced annotation step to increase the "max. number of words per cluster label" to the largest possible value of 5. Cluster annotations were generated using WordCloud (Oesper, Merico, Isserlin, & Bader, 2011) v3.1.1, downloaded January 2018.
In the Supplement, we further describe in detail how we overlaid expression data onto the pathway maps, constructed the overlap of healthspan pathways in C.elegans and humans, and programmed the web presentation.
Supporting Information listing
Supplementary genes are shown in blue, and grey denotes genes for which no expression values are available in the caloric restriction dataset (Mercken et al. 2013) . The color of an edge refers to the source of the edge in the underlying network, that is co-expression (pink), common pathway (green), physical interactions (red), shared protein domains (brown), co-localization (blue), predicted (orange), and genetic interaction (green). The thickness of an edge is proportional to its GeneMANIA "normalized max weight", based on the network data. Genes from the GeneMANIA input list feature a thick circle, while genes added by GeneMANIA do not. from the respective other species. We then employed GeneMANIA as before, to generate two interaction networks (one per list). and overlaps between these two networks of health genes were determined by GASOLINE (middle, see also Figure 5 ). 
